A meta-meta-analysis: Evaluation of meta-analyses published in the effectiveness of cardiovascular comorbidities on the severity of COVID-19 [0.03%]
一项关于心血管合并症对新冠肺炎病情严重程度的影响的系统评价和荟萃分析的meta-荟萃分析研究：系统的系统评价与荟萃分析
Mehri Bemani Naeini,Mahdieh Sahebi,Fateme Nikbakht et al.
Mehri Bemani Naeini et al.
On January 2020, WHO confirmed the epidemic outbreak of SARS-CoV-2 as a Health Emergency of International Concern. The aim of this meta-meta-analysis is quantifying meta-analytic findings on the association of cardiovascular disease (CVD) c...
Hypoxia-inducible factor (HIF): The link between obesity and COVID-19 [0.03%]
肥胖与COVID-19之间的联系：缺氧诱导因子(HIF)的作用机制及其药物作用靶点
Antoine AbdelMassih,Elaria Yacoub,Reem J Husseiny et al.
Antoine AbdelMassih et al.
The COVID-19 death toll has involved to date more than 1 million confirmed deaths. The death rate is even higher in the obese COVID-19 patients, as a result of hypoxia, due to the interplay between adipose tissue hypoxia and obstructive sle...
Friend or foe? ACE2 inhibitors and GLP-1R agonists in COVID-19 treatment [0.03%]
friendorfo敌友难辨？ARNI和GLP-1受体激动剂在新冠肺炎治疗中的作用
Juan Pang,Mingyao Liu,Wenhua Ling et al.
Juan Pang et al.
COVID-19, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been a pandemic since WHO made the statement on March 11, 2020. The infection is causing a high mortality in old people, especially those with obesity, ty...
Type 2 diabetes is associated with increased risk of critical respiratory illness in patients COVID-19 in a community hospital [0.03%]
2型糖尿病与社区医院COVID-19患者严重呼吸道疾病风险增加有关
Ekta Shrestha,Mariam Charkviani,Clio Musurakis et al.
Ekta Shrestha et al.
Background: Type 2 diabetes (T2D) is the leading non-communicable disease worldwide and is associated with several microvascular and macrovascular complications. Individuals with T2D are more prone to acquiring selected t...
Single cell sequencing unraveling genetic basis of severe COVID19 in obesity [0.03%]
单细胞测序揭示肥胖患者严重COVID19的遗传基础
Antoine Fakhry AbdelMassih,Raghda Fouda,Aya Kamel et al.
Antoine Fakhry AbdelMassih et al.
COVID-19 has shown a substantial variation in the rate and severity by which it impacts different demographic groups. Specifically, it has shown a predilection towards obese patients as well as well as other vulnerable groups including pred...
Gut microbiome dysbiosis and endotoxemia - Additional pathophysiological explanation for increased COVID-19 severity in obesity [0.03%]
肠道菌群失调和内毒素血症 - 为肥胖患者中COVID-19病情加重提供额外的病理生理学解释
Andrej Belančić
Andrej Belančić
The overall intestinal lipopolysaccharide (LPS) composition in the individuals with obesity could be shifted away from immunosilent/immunoinhibitory Bacteroidetes LPS subtypes, in favor of various proinflammatory LPS subtypes due to gut mic...
The Temple Vie weight management and lifestyle programme: initial data and reflections on Covid-19 [0.03%]
Temple Vie体重管理和生活方式项目：初期数据和对Covid-19的反思
Samantha J Robson,John M Eagles
Samantha J Robson
During the first three months of the Temple Vie programme, average weight loss in 36 subjects exceeded 13 kg. There were associated improvements in Patient Reported Outcome Measures, blood pressure and serum lipids. The Covid-19 pandemic ma...
Metformin use is associated with reduced mortality rate from coronavirus disease 2019 (COVID-19) infection [0.03%]
使用二甲双胍与冠状病毒疾病2019（COVID-19）感染的死亡率降低有关
Timotius Ivan Hariyanto,Andree Kurniawan
Timotius Ivan Hariyanto
Background and aims: The coronavirus disease 2019 (COVID-19) pandemic has caused a significant impact on all aspects of life. One of the comorbidities associated with severe outcome and mortality of COVID-19 is diabetes. ...
Obesity risk during collective quarantine for the COVID-19 epidemic [0.03%]
流行性疾病COVID-19集体隔离期间的肥胖风险问题
Anna Vittoria Mattioli,Marcello Pinti,Alberto Farinetti et al.
Anna Vittoria Mattioli et al.
In March 2020, when COVID-19 epidemics involved several countries, the WHO defined the infection as a pandemic. Government adopted measures to prevent the diffusion of infection; i.e. quarantine and isolation. One of the consequences of qua...
"Weighing" the risks and benefits - Thromboprophylaxis challenges in obese COVID-19 patients [0.03%]
“衡量”风险和益处-肥胖COVID-19患者的抗血栓形成的挑战
Venkata Ram Pradeep Rokkam,Radhakrishna Vegunta,Kalyan Prudhvi et al.
Venkata Ram Pradeep Rokkam et al.